Header Logo

Connection

Sarju Ganatra to Ritonavir

This is a "connection" page, showing publications Sarju Ganatra has written about Ritonavir.
Connection Strength

1.105
  1. Ganatra S, Dani SS, Ahmad J, Kumar A, Shah J, Abraham GM, McQuillen DP, Wachter RM, Sax PE. Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019. Clin Infect Dis. 2023 02 18; 76(4):563-572.
    View in: PubMed
    Score: 0.843
  2. Abraham S, Nohria A, Neilan TG, Asnani A, Saji AM, Shah J, Lech T, Grossman J, Abraham GM, McQuillen DP, Martin DT, Sax PE, Dani SS, Ganatra S. Cardiovascular Drug Interactions With?Nirmatrelvir/Ritonavir in Patients?With COVID-19: JACC?Review Topic of the Week. J Am Coll Cardiol. 2022 11 15; 80(20):1912-1924.
    View in: PubMed
    Score: 0.206
  3. Faust JS, Kumar A, Shah J, Khadke S, Dani SS, Ganatra S, Sax PE. Oral Nirmatrelvir and Ritonavir for Coronavirus Disease 2019 in Vaccinated, Nonhospitalized Adults Aged 18-50 Years. Clin Infect Dis. 2023 11 11; 77(9):1257-1264.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.